RTW Investments

RTW Investments is a life sciences investment and innovation firm that partners with biotech and medtech companies across their full lifecycle, from early company creation through venture capital, alternative financing, and public markets. Rather than acting purely as a capital provider, the firm positions itself as a hands-on partner, combining scientific expertise with a long-term investment horizon to help build companies around promising research.

The firm is led by Roderick Wong, MD, Managing Partner and Chief Investment Officer, alongside a leadership team that includes Kinnari Patel, PharmD, MBA as Chief Executive Officer, Peter Fong, PhD as Partner and President, and Robert Aurigema as Partner, COO and CFO. RTW’s team blends doctors, academics, drug developers, venture investors, and company operators, reflecting its multidisciplinary approach to identifying and developing therapies.

RTW also manages RTW Biotech Opportunities Ltd, a vehicle focused on transformative life sciences investments, and supports its mission through the RTW Foundation and RTW Institute, extending its focus on patient impact beyond pure investment returns.